Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Diabetes Mellitus Type 1

Interventions

DRUG

BioChaperone insulin lispro

Single dose of 0.2 U/kg body weight injected subcutaneously

DRUG

Humalog®

Single dose of 0.2 U/kg body weight injected subcutaneously

Trial Locations (1)

Profil GmbH, Neuss